# Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

> **NCT01016639** · PHASE1,PHASE2 · COMPLETED · sponsor: **Lund University Hospital** · enrollment: 106 (actual)

## Conditions studied

- Stomach Cancer
- Gall Bladder Cancer
- Bile Ductus Cancer
- Pancreas Cancer
- Colorectal Cancer

## Interventions

- **OTHER:** oxaliplatin, capecitabine, radiotherapy

## Key facts

- **NCT ID:** NCT01016639
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-07
- **Final completion:** 2009-07
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2011-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016639, "Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01016639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*